Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 2
1992 4
1993 6
1994 3
1995 3
1996 6
1997 9
1998 9
1999 9
2000 14
2001 4
2002 4
2003 9
2004 8
2005 7
2006 8
2007 6
2008 5
2009 7
2010 3
2011 6
2012 16
2013 18
2014 16
2015 12
2016 16
2017 26
2018 30
2019 32
2020 32
2021 17
2022 28
2023 34
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
France: Health System Review.
Chevreul K, Berg Brigham K, Durand-Zaleski I, Hernandez-Quevedo C. Chevreul K, et al. Among authors: durand zaleski i. Health Syst Transit. 2015;17(3):1-218, xvii. Health Syst Transit. 2015. PMID: 26766545 Free article. Review.
Effect of Prehabilitation Before Total Knee Replacement for Knee Osteoarthritis on Functional Outcomes: A Randomized Clinical Trial.
Nguyen C, Boutron I, Roren A, Anract P, Beaudreuil J, Biau D, Boisgard S, Daste C, Durand-Zaleski I, Eschalier B, Gil C, Lefèvre-Colau MM, Nizard R, Perrodeau É, Rabetrano H, Richette P, Sanchez K, Zalc J, Coudeyre E, Rannou F. Nguyen C, et al. Among authors: durand zaleski i. JAMA Netw Open. 2022 Mar 1;5(3):e221462. doi: 10.1001/jamanetworkopen.2022.1462. JAMA Netw Open. 2022. PMID: 35262716 Free PMC article. Clinical Trial.
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, Cachanado M, Durand-Zaleski I, Arnaiz JA, Martínez-Sellés M, Silvain J, Ariza-Solé A, Ferrari E, Calvo G, Danchin N, Avendaño-Solá C, Frenkiel J, Rousseau A, Vicaut E, Simon T, Steg PG; REALITY Investigators. Ducrocq G, et al. Among authors: durand zaleski i. JAMA. 2021 Feb 9;325(6):552-560. doi: 10.1001/jama.2021.0135. JAMA. 2021. PMID: 33560322 Free PMC article. Clinical Trial.
Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest.
François B, Cariou A, Clere-Jehl R, Dequin PF, Renon-Carron F, Daix T, Guitton C, Deye N, Legriel S, Plantefève G, Quenot JP, Desachy A, Kamel T, Bedon-Carte S, Diehl JL, Chudeau N, Karam E, Durand-Zaleski I, Giraudeau B, Vignon P, Le Gouge A; CRICS-TRIGGERSEP Network and the ANTHARTIC Study Group. François B, et al. Among authors: durand zaleski i. N Engl J Med. 2019 Nov 7;381(19):1831-1842. doi: 10.1056/NEJMoa1812379. N Engl J Med. 2019. PMID: 31693806 Clinical Trial.
Place des mesures rapportées par les patients (PROMS/PREMS) dans l’évaluation et la valorisation des technologies de santé en France.
Roussel C, Chassany O, Durand-Zaleski I, Josseran A, Alter L, Auquier P, Bourguignon S, Cachoux J, Desforges C, Fernandez J, Gaudin AF, Germe AF, Haenel E, Olivier P, Maillard N, Naïditch N, Nguyen T, Péan C, Rumeau-Pichon C, Sales JP, Schmidely N, Tuppin P, Vray M. Roussel C, et al. Among authors: durand zaleski i. Therapie. 2022 Jan-Feb;77(1):89-102. doi: 10.1016/j.therap.2022.01.007. Epub 2022 Jan 13. Therapie. 2022. PMID: 35115142 French. No abstract available.
Données et preuves en vie réelle dans l’évaluation des technologies de santé : dans quels cas sont-elles complémentaires, substitutives, ou les seules sources de données par rapport aux essais cliniques ?
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, Beziz D, Blin P, Borget I, Bouée S, Collignon C, Dervaux B, Durand-Zaleski I, Julien M, de Léotoing L, Majed L, Martelli N, Séjourné T, Viprey M. de Pouvourville G, et al. Among authors: durand zaleski i. Therapie. 2023 Jan-Feb;78(1):66-80. doi: 10.1016/j.therap.2022.10.067. Epub 2022 Oct 29. Therapie. 2023. PMID: 36446648 French. No abstract available.
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G; CLOSE Investigators. Mas JL, et al. N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915. N Engl J Med. 2017. PMID: 28902593 Free article. Clinical Trial.
High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold.
Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B, Bihan H, Julla JB, Radu A, Poynard T, Brzustowsky A, Larger E, Czernichow S, Pol S, Bedossa P, Valla D, Gautier JF; QUID-NASH investigators. Castera L, et al. Diabetes Care. 2023 Jul 1;46(7):1354-1362. doi: 10.2337/dc22-2048. Diabetes Care. 2023. PMID: 37043830
386 results